BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 16116304)

  • 21. Hospitalization causes and outcomes in HIV patients in the late antiretroviral era in Colombia.
    Álvarez Barreneche MF; Restrepo Castro CA; Hidrón Botero A; Villa Franco JP; Trompa Romero IM; Restrepo Carvajal L; Eusse García A; Ocampo Mesa A; Echeverri Toro LM; Porras Fernández de Castro GP; Ramírez Rivera JM; Agudelo Restrepo CA
    AIDS Res Ther; 2017 Nov; 14(1):60. PubMed ID: 29132400
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Absolute CD4 vs. CD4 percentage for predicting the risk of opportunistic illness in HIV infection.
    Gebo KA; Gallant JE; Keruly JC; Moore RD
    J Acquir Immune Defic Syndr; 2004 Aug; 36(5):1028-33. PubMed ID: 15247555
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk factors for AIDS-defining illnesses among a population of poorly adherent people living with HIV/AIDS in Atlanta, Georgia.
    Chow JY; Alsan M; Armstrong W; del Rio C; Marconi VC
    AIDS Care; 2015; 27(7):844-8. PubMed ID: 25660100
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pulmonary manifestations of HIV infection in the era of highly active antiretroviral therapy.
    Wolff AJ; O'Donnell AE
    Chest; 2001 Dec; 120(6):1888-93. PubMed ID: 11742918
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Causes of first hospitalization among 1121 HIV-infected children: comparison of the pre-Pneumocystis jiroveci pneumonia prophylaxis, pre-antiretroviral therapy and antiretroviral therapy periods.
    Sudjaritruk T; Oberdorfer P; Puthanakit T; Sirisanthana T; Sirisanthana V
    Int J STD AIDS; 2012 May; 23(5):335-9. PubMed ID: 22648887
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bacterial pneumonia in hospitalized patients with HIV infection: the Pulmonary Complications, ICU Support, and Prognostic Factors of Hospitalized Patients with HIV (PIP) Study.
    Afessa B; Green B
    Chest; 2000 Apr; 117(4):1017-22. PubMed ID: 10767233
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of antiretroviral therapy on decreasing hospitalization rates of HIV-infected patients in 2001.
    Paul S; Gilbert HM; Lande L; Vaamonde CM; Jacobs J; Malak S; Sepkowitz KA
    AIDS Res Hum Retroviruses; 2002 May; 18(7):501-6. PubMed ID: 12015903
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pneumocystis carinii pneumonia in HIV-infected patients in the HAART era.
    Pulvirenti J; Herrera P; Venkataraman P; Ahmed N
    AIDS Patient Care STDS; 2003 Jun; 17(6):261-5. PubMed ID: 12880489
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is it safe to discontinue primary Pneumocystis jiroveci pneumonia prophylaxis in patients with virologically suppressed HIV infection and a CD4 cell count <200 cells/microL?
    ; Mocroft A; Reiss P; Kirk O; Mussini C; Girardi E; Morlat P; Stephan C; De Wit S; Doerholt K; Ghosn J; Bucher HC; Lundgren JD; Chene G; Miro JM; Furrer H
    Clin Infect Dis; 2010 Sep; 51(5):611-9. PubMed ID: 20645862
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hospitalizations in a cohort of HIV patients in Australia, 1999-2007.
    Falster K; Wand H; Donovan B; Anderson J; Nolan D; Watson K; Watson J; Law MG;
    AIDS; 2010 Jun; 24(9):1329-39. PubMed ID: 20559038
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictors of opportunistic illnesses incidence in post combination antiretroviral therapy era in an urban cohort from Rio de Janeiro, Brazil.
    Coelho LE; Cardoso SW; Amancio RT; Moreira RI; Ribeiro SR; Coelho AB; Campos DP; Veloso VG; Grinsztejn B; Luz PM
    BMC Infect Dis; 2016 Mar; 16():134. PubMed ID: 27001753
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Response to HAART in treatment-naive HIV-infected patients with a prior diagnosis of tuberculosis or other opportunistic infections.
    Dronda F; Sobrino P; Hernández-Novoa B; Caro-Murillo AM; Montero M; Iribarren JA; Sanz J; Del Mar Alonso M; Labarga P; Bernal E; Moreno S;
    Curr HIV Res; 2011 Jun; 9(4):229-36. PubMed ID: 21631429
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gender differences in quality of HIV care in Ryan White CARE Act-funded clinics.
    Hirschhorn LR; McInnes K; Landon BE; Wilson IB; Ding L; Marsden PV; Malitz F; Cleary PD
    Womens Health Issues; 2006; 16(3):104-12. PubMed ID: 16765286
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trends in hospital admissions, re-admissions, and in-hospital mortality among HIV-infected patients between 1993 and 2013: Impact of hepatitis C co-infection.
    Meijide H; Mena Á; Rodríguez-Osorio I; Pértega S; Castro-Iglesias Á; Rodríguez-Martínez G; Pedreira J; Poveda E
    Enferm Infecc Microbiol Clin; 2017 Jan; 35(1):20-26. PubMed ID: 27609631
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hospitalization rates of people living with HIV in the United States, 2009.
    Bachhuber MA; Southern WN
    Public Health Rep; 2014; 129(2):178-86. PubMed ID: 24587553
    [TBL] [Abstract][Full Text] [Related]  

  • 36. US hospital care for patients with HIV infection and pneumonia: the role of public, private, and Veterans Affairs hospitals in the early highly active antiretroviral therapy era.
    Uphold CR; Deloria-Knoll M; Palella FJ; Parada JP; Chmiel JS; Phan L; Bennett CL
    Chest; 2004 Feb; 125(2):548-56. PubMed ID: 14769737
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [HIV patient hospitalization during the pre and post-HAART era].
    Pérez E; Toibaro JJ; Losso MH
    Medicina (B Aires); 2005; 65(6):482-8. PubMed ID: 16433473
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The changing pattern of AIDS-defining illnesses with the introduction of highly active antiretroviral therapy (HAART)in a London clinic.
    Ives NJ; Gazzard BG; Easterbrook PJ
    J Infect; 2001 Feb; 42(2):134-9. PubMed ID: 11531320
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association between Highly Active Antiretroviral Therapy and Type of Infectious Respiratory Disease and All-Cause In-Hospital Mortality in Patients with HIV/AIDS: A Case Series.
    Báez-Saldaña R; Villafuerte-García A; Cruz-Hervert P; Delgado-Sánchez G; Ferreyra-Reyes L; Ferreira-Guerrero E; Mongua-Rodríguez N; Montero-Campos R; Melchor-Romero A; García-García L
    PLoS One; 2015; 10(9):e0138115. PubMed ID: 26379281
    [TBL] [Abstract][Full Text] [Related]  

  • 40. AIDS-defining opportunistic illnesses in the HAART era in New York City.
    Hanna DB; Gupta LS; Jones LE; Thompson DM; Kellerman SE; Sackoff JE
    AIDS Care; 2007 Feb; 19(2):264-72. PubMed ID: 17364409
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.